LOXL1 Adenovirus (Human)
-
Catalog number104562A
-
PricePlease ask
-
Size250ul
-
-
Product typeAdenovirus
-
Detection and sensitivityBefore using LOXL1 Adenovirus (Human) please read the package insert. It is intended for Human reactivity. Accession Number: NM_005576
-
Performance and applicationsPlease contact Gentaur's support by livechat, email or phone in order to receive the requested information. The product is for research use only.
-
Additional informationThe LOXL1 Adenovirus (Human) could be additionally purified if wanted from the customer. Please contact our sales representative to obtain more information.
-
Shipping handling and storageLOXL1 Adenovirus (Human) should be stored according to label on the vial.
-
PropertiesHuman proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
-
Gene target
-
Gene symbolLOXL1-AS1, LOXL1
-
Short nameLOXL1 Adenovirus ( )
-
SpeciesHuman, Humans
-
Alternative nameLOXL1 Adenovirus (H. sapiens)
-
Virusadenovirus
-
Gene info
-
Identity
-
Gene
-
Long gene nameLOXL1 antisense RNA 1
-
Synonyms gene name
- LOXL1 antisense RNA 1 (non-protein coding)
-
GenBank acession
-
Locus
-
Discovery year2012-06-30
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Antisense RNAs
-
VEGA ID
Gene info
-
Identity
-
Gene
-
Long gene namelysyl oxidase like 1
-
Synonyms gene name
- lysyl oxidase-like 1
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1993-12-08
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
VEGA ID
MeSH Data
-
Name
-
ConceptScope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
-
Tree numbers
- E05.393.220
-
Qualifiersdrug effects, methods, radiation effects